A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial

Ali Abbara(Imperial College Healthcare NHS Trust), Waljit S. Dhillo(Imperial College Healthcare NHS Trust), Geoffrey Trew(Reproductive Medicine Institute), Chioma Izzi‐Engbeaya(Imperial College Healthcare NHS Trust), Julia Prague(Hammersmith Hospital), Alexander Nesbitt(American Society for Investigative Pathology), Alexander Comninos(Imperial College Healthcare NHS Trust), Rachel Roberts(Imperial College London), Sunitha Vimalesvaran(Hammersmith Hospital), Sophie Clarke(Imperial College London), Rumana Islam(Hammersmith Hospital), Stuart Lavery(Hammersmith Hospital), Rehan Salim(Hammersmith Hospital), Les Huson(Hammersmith Hospital), Deborah Papadopoulou(Imperial College London), Stephen R. Bloom(Imperial College London), Shakunthala Narayanaswamy(Hammersmith Hospital), Risheka Ratnasabapathy(Hammersmith Hospital)
Human Reproduction
July 24, 2017
Cited by 69


Related Papers